国家食品药品监督管理局
Due to the high cost of sofosbuvir in the United States, as of 2016 increasing numbers of Americans with hepatitis C were traveling to India to purchase it. Similarly, increasing numbers of Chinese were also traveling to India to purchase sofosbuvir, which had not yet been approved for sale in China by the country's State Food and Drug Administration (SFDA).